Estimating the cost of strategic entry delay in pharmaceuticals: The case of Ambien CR-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Estimating the cost of strategic entry delay in pharmaceuticals: The case of Ambien CR

Published:2016-08-25 Issue:3 Volume:14 Page:201-231
ISSN:1570-7156
Container-title:Quantitative Marketing and Economics
language:en
Short-container-title:Quant Mark Econ

Author:

Shapiro Bradley T.^ORCID

Funder

National Institute on Aging

University of Chicago Booth School of Business

Publisher

Springer Science and Business Media LLC

Subject

Marketing,Economics, Econometrics and Finance (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1007/s11129-016-9170-9.pdf

Reference19 articles.

1. Abaluck, J., Gruber, J., & Swanson, A. (2015). Prescription drug use under medicare part D: a linear model of nonlinear budget sets. NBER Working Paper No. 20976.

2. Adams, C.P., & Brantner, V.V. (2006). Estimating the cost of new drug development: is it really $802 million? Health Affairs, 25(2), 420–428.

3. Aitken, M.L., Berndt, E.R., Bosworth, B., Cockburn, I.M., Frank, R., Kleinrock, M., & Shapiro, B.T. (2013). The regulation of prescription drug competition and market responses: patterns in prices and sales following loss of exclusivity. NBER Working Paper No. 19487.

4. Berry, S., Levinsohn, J., & Pakes, A. (1995). Automobile prices in market equilibrium. Econometrica, 63(4), 841–890.

5. Berry, S.T. (1994). Estimating discrete-choice models of product differentiation. The RAND Journal of Economics, 25(2), 242–262.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Approvals and Timing of New Formulations of Novel Drugs Approved by the US Food and Drug Administration Between 1995 and 2010 and Followed Through 2021;JAMA Health Forum;2022-05-20

2. Effect of Patent Expiry on the Performance of Innovator Multinational Pharmaceutical Companies in a Low Middle Income Country;Frontiers in Medical Technology;2022-04-04

3. History-Dependence in Drug Demand: Identification and Implications for Entry Incentives;The Review of Economics and Statistics;2022-01-25

4. Welfare effects of public procurement of medicines: Evidence from Ecuador;International Journal of Industrial Organization;2021-03

5. Entry threat, entry delay, and Internet speed: The timing of the U.S. broadband rollout;Journal of Economics & Management Strategy;2020-11-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3